🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Docon offloads 10% stake in Thyrocare for Rs 668 Cr

EntrackrEntrackr · 3m ago
Docon offloads 10% stake in Thyrocare for Rs 668 Cr
Medial

Docon Technologies Pvt Ltd, a promoter entity of Thyrocare Technologies, has sold 53.33 lakh equity shares representing around 10% of the company’s total paid-up capital through open market transactions on October 24, 2025. The sale was valued at Rs 667.7 crore at an average price of Rs 1,252 per share, according to a stock exchange filing. Following the transaction, Docon’s shareholding in Thyrocare has come down from 71% to 61% and continues to remain a promoter of the diagnostics chain with 3.2 crore shares. The block sale saw strong participation from domestic mutual funds. Among the key buyers were ICICI Prudential Mutual Fund, which purchased 17.49 lakh shares worth Rs 218.9 crore, and Aditya Birla Sun Life Mutual Fund, which picked up 10.33 lakh shares for Rs 129.3 crore. Other prominent investors included HSBC Mutual Fund Midcap Fund (6.66 lakh shares for Rs 83.4 crore), HDFC Mutual Fund (4.44 lakh shares for Rs 55.5 crore), and Eastspring Investments India Consumer Equity Open Limited (3.19 lakh shares for Rs 40 crore). The stake sale comes on the back of leadership transition within the PharmEasy-Thyrocare group. In August 2025, PharmEasy’s co-founder and CEO Siddharth Shah stepped down from his executive role to become the company’s Vice Chairman, while Thyrocare’s chief Rahul Guha was elevated as the new MD and CEO of API Holdings, the parent entity of PharmEasy and Thyrocare. Guha continues to lead Thyrocare alongside his expanded responsibilities at API. Thyrocare recently announced its financial numbers for the second quarter of the ongoing fiscal year FY26, posting a strong performance in the quarter. The company’s revenue from operations grew 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26 from Rs 177.36 crore in Q2 FY25. Thyrocare’s profit jumped 81% YoY to Rs 47.9 crore in Q2 FY26, compared to Rs 26.4 crore in the corresponding quarter last year. For the first half of FY26, the company recorded a net profit that grew 71% to Rs 86.1 crore from Rs 50.4 crore in H1 FY25.

EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions

EntrackrEntrackr · 5m ago
EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions
Medial

EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions Online travel aggregator (OTA) platform EaseMyTrip has reported dismal performance during the last quarter, with revenue declining over 25% and profit plunging 98% to Rs 44 lakh. EaseMyTrip’s operating revenue decreased by 25.5% to Rs 114 crore in Q1 FY26 from Rs 25.5 crore in Q1 FY25, as per its financial statements filed with the National Stock Exchange (NSE). Air ticketing contributed 50% of the company’s revenue but fell 47% to Rs 57 crore in Q1 FY26, down from Rs 107 crore in Q1 FY25. Hotel packages accounted for 28.5% of total revenue, generating Rs 32.5 crore. Including other undisclosed income, its total income for Q1 FY26 stood at Rs 120 crore, compared to Rs 156 crore in Q1 FY25. On a quarter-on-quarter basis, EaseMyTrip’s operating revenue fell 18% to Rs 114 crore in Q1 FY26 from Rs 139 crore in Q4 FY25. In line with its scale, total expenses rose 8% to Rs 118 crore in Q1 FY26 from Rs 109 crore in Q1 FY25. Service costs accounted for 15% of the total, falling 5% to Rs 18 crore in Q1 FY26. Payment gateway charges, employee benefits, and advertising were other major costs for EaseMyTrip in the last quarter. EaseMyTrip’s profit after tax (PAT) fell 98.7% to Rs 44 lakh in Q1 FY26 as compared to Rs 34 crore in Q1 FY25. On a unit basis, the Delhi-based company spent Rs 1.04 to earn a rupee of operating revenue with EBITDA of Rs 6.2 crore during the last quarter. In its board meeting, the company also approved an investment of Rs 175 crore in Three Falcons Notting Hill Limited for a 50% stake, the acquisition of 100% stake in AB Finance Private Limited for Rs 194.4 crore, and approved an investment in Vashu Bhagnani Industries Limited. EaseMyTrip closed Thursday's trading session at Rs 9.22, with a 4% increase in its share price. The company’s total market capitalization stood at Rs 3,353 crore (approx $383 million).

Paytm posts Rs 2,194 Cr revenue and Rs 225 Cr profit in Q3 FY26

EntrackrEntrackr · 2d ago
Paytm posts Rs 2,194 Cr revenue and Rs 225 Cr profit in Q3 FY26
Medial

Fintech firm Paytm announced its financial results for the third quarter of the ongoing fiscal year (Q3 FY26) on Thursday. The Noida-based company reported a revenue of Rs 2,194 crore and a net profit of Rs 225 crore for the period. According to Paytm’s unaudited quarterly report filed with the National Stock Exchange, its revenue from operations increased by 20% year-on-year from Rs 1,828 crore in Q3 FY25. The company also added Rs 212 crore from other non-operating sources, bringing its overall revenue to Rs 2,406 crore in Q3 FY26. For the nine-months period, Paytm’s revenue rose 24% to Rs 6,173 crore from Rs 4,989 crore, a year earlier. For the Noida-based firm, its employee benefits remained the largest cost center, accounting for 33% of the overall cost, which decreased by 5% to Rs 721 crore in Q3 FY26. Its payment processing charges increased by 17.5% to Rs 671 crore, and marketing expenses increased by 3.5% to Rs 146 crore in Q3 FY26. Software, communication, legal, cashback, and other overheads took the total expenditure to Rs 2,175 crore in Q3 FY26, as compared to Rs 2,220 crore in Q3 FY25. Paytm recorded a net profit of Rs 225 crore in Q3 FY26, in contrast to a loss of Rs 208 crore in Q3 FY25. On a sequential basis, the company’s profit increased by more than 10X from Rs 21 crore in Q2 FY26. Last quarter was eventful for the company as it received authorisation from the RBI to operate as a payment aggregator for physical or offline payments and cross border transactions. The company also granted ESOPs worth Rs 16.6 crore and Rs 60 crore under its ESOP Scheme 2019. Paytm also witnessed a significant shareholder shift as Elevation Capital (formerly SAIF Partners) offloaded a 1.86% stake in the fintech major through a bulk deal worth Rs 1,556 crore. Five days later, BNP Paribas sold 1 crore shares of Paytm worth Rs 1,331 crore. Alongside this, Integrated Core Strategies sold 32.55 lakh shares worth Rs 410 crore. As of January 29, Paytm’s share price stood at Rs 1,172 with the total market capitalization standing at Rs 74,963 crore ($8 billion).

Blackbuck records Rs 29 Cr profit on Rs 151 Cr revenue in Q2 FY26

EntrackrEntrackr · 2m ago
Blackbuck records Rs 29 Cr profit on Rs 151 Cr revenue in Q2 FY26
Medial

Blackbuck records Rs 29 Cr profit on Rs 151 Cr revenue in Q2 FY26 Blackbuck has released its financial report for the second quarter of the ongoing financial year ending September 2025. The Bengaluru-based company reported a 52.5% year-on-year growth in scale in Q2 FY26 and posted a profit of Rs 29 crore in the quarter. Blackbuck's revenue from operations grew to Rs 151 crore in Q2 FY26 from Rs 99 crore in Q2 FY25, its financial statements sourced from the National Stock Exchange (NSE) show. On a quarter-on-quarter basis, Blackbuck’s operating revenue increased 5.6% from Rs 143 crore in Q1 FY26. The company’s gross transaction value (GTV) stood at Rs 6778.3 crore in the same quarter. On a half-yearly basis, the company’s revenue increased by 54.5% to Rs 295 crore in H1 FY26 as compared to Rs 191 crore in H1 FY25. Revenue from its truck operator services was the primary source of revenue, accounting for 98% of total operating revenue. The company also made Rs 17 crore from interest income which took its overall revenue to Rs 168 crore in Q2 FY26, compared to Rs 104 crore in Q2 FY25. Looking at the expenses, the employee benefit cost accounted for 33% of the overall expenditure which increased by 6% year-on-year to Rs 42 crore in Q2 FY26 from Rs 39.5 crore in Q2 FY25. Deprecation and other operating expenses were key overheads that drove total expenditure to Rs 128 crore in Q2 FY26, compared to Rs 92 crore in the same quarter last year. Blackbuck registered a profit of Rs 29 crore in Q2 FY26, as compared to a loss of Rs 269 crore in Q2 FY25. On a quarterly basis, the company’s profit fell 54% from Rs 63 crore in Q1 FY26. For the six months ending September 2025, the company posted a profit of Rs 63 crore. At the end of the last trading session, Blackbuck’s share price stood at Rs 666.5, giving the company a market capitalization of Rs 12,045 crore ($1.3 billion).

Pine Labs posts Rs 42 Cr profit in Q3 FY26; revenue grows 24%

EntrackrEntrackr · 3d ago
Pine Labs posts Rs 42 Cr profit in Q3 FY26; revenue grows 24%
Medial

Fintech major Pine Labs announced its financial results for Q3 FY26 after debuting on Indian stock exchanges in the same quarter. The firm’s revenue increased by 24% during the third quarter, while it remained profitable in the same period. The company’s revenue from operations increased to Rs 744 crore in Q3 FY26 from Rs 601 crore in the same quarter last year, according to its financial statement sourced from NSE. Other income contributed an additional Rs 36 crore, which drove its total income to Rs 780 crore for the quarter. For the nine-month period ending December 2025, the firm’s revenue increased 20% to Rs 2,010 crore from Rs 1,676 crore, a year earlier. On the expense side, employee benefit was the largest cost centre, which accounted for 37% of the total expense. This cost increased by 5% to Rs 263 crore in Q3 FY26 from Rs 251 crore in Q3 FY25. Cost of material rose 51% to Rs 104 crore in Q3 FY26 from Rs 69 crore in Q3 FY25. Finance cost and depreciation cost were other overheads which led to the total expense to increase by 13% to Rs 705 crore in Q3 FY26. Pine Labs entered profitability on the back of steady growth and disciplined cost control, reporting a net profit of Rs 42 crore in Q3 FY26 versus a loss of Rs 57 crore in Q3 FY25. For the nine-month period, the company posted a profit of Rs 53 crore. Pine Labs made a positive debut on the public markets, listing at a 9.5% premium over its issue price. The stock opened at Rs 242 per share against the IPO price of Rs 221, giving the Peak XV-backed firm a stable start on the NSE and BSE. Earlier this month, Pine Labs received RBI approval to fully acquire RBI-licensed account aggregator Agya Technologies, increasing its stake to 100% from its previous associate company status. The company’s share is trading at Rs 233, giving it a market capitalization of Rs 26,736 crore (approximately $2.9 billion).

Download the medial app to read full posts, comements and news.